The Korea Disease Control and Prevention Agency scales back Q1 vaccination targets to 750,000 people due to delayed shipments from COVAX and the decision not to use the AstraZeneca vaccine on people aged 65 or older until more efficacy data becomes available.
The Korea Disease Control and Prevention Agency scale back Q1 vaccination targets to 750,000 due to delayed shipments from COVAX and don't use AstraZeneca's vaccine for people aged 65 or older until more efficacy data becomes avaliable.
The Korea Disease Control and Prevention Agency scales back Q1 vaccination targets to 750,000 due to delayed shipments from COVAX and thedecisionnotto use AstraZeneca's vaccine for people aged 65 or older until more efficacy data becomes avaliable.
The Korea Disease Control and Prevention Agency scales back Q1 vaccination targets to 750,000 peopledue to delayed shipments from COVAX and the decision not to use theAstraZeneca vaccine on people aged 65 or older until more efficacy data becomes available.
